
Omid A. Hamid, MD, chief of Translational Research and Immunotherapy, director, Melanoma Therapeutics, The Angeles Clinic and Research Institute, discusses options for patients with melanoma who have exhausted standard therapies.

Your AI-Trained Oncology Knowledge Connection!


Published: February 20th 2018 | Updated: